Journal Article

DKFZ-2023-02088

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png S3 guideline 'actinic keratosis and cutaneous squamous cell carcinoma' - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.

Leiter, U. ; Heppt, M. V. ; Steeb, T. ; Alter, M. ; Amaral, T. ; Bauer, A. ; Bechara, F. G. ; Becker, J.DKFZ* ; Breitbart, E. W. ; Breuninger, H. ; Diepgen, T. ; Dirschka, T. ; Eigentler, T. ; ElGammal, A. K. S. ; Felcht, M. ; Flaig, M. J. ; Follmann, M. ; Fritz, K. ; Grabbe, S. ; Greinert, R. ; Gutzmer, R. ; Hauschild, A. ; Hillen, U. ; Ihrler, S. ; John, S. M. ; Kofler, L. ; Koelbl, O. ; Krause-Bergmann, A. ; Kraywinkel, K. ; Krohn, S. ; Langer, T. ; Loquai, C. ; Löser, C. R. ; Mohr, P. ; Nashan, D. ; Nothacker, M. ; Pfannenberg, C. ; Salavastru, C. ; Schmitz, L. ; Stockfleth, E. ; Szeimies, R.-M. ; Ulrich, C. ; Voelter-Mahlknecht, S. ; Vordermark, D. ; Weichenthal, M. ; Welzel, J. ; Wermker, K. ; Wiegand, S. ; Garbe, C. ; Berking, C.

2023
Wiley-Blackwell Berlin

This record in other databases:

Please use a persistent id in citations: doi:10.1111/ddg.15256

Abstract: Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline 'actinic keratosis and cutaneous squamous cell carcinoma' was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen's disease) and actinic cheilitis. The guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate guideline exists for patients and their relatives. In this part, we will address aspects relating to epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.

Note: 2023 Nov;21(11):1422-1434 / doi: 10.1111/ddg.15256_g / PMID: 37946644

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2023

---

Database coverage:
; Clarivate Analytics Master Journal List ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---